Search
1 - 15 of 15 items
Prognostic Value of the Systemic Immune-Inflammation Index in EGFR Mutation-Positive Lung Adenocarcinoma Patients Treated with Tyrosine Kinase Inhibitors
133-139
Abstract : 1259
PDF : 531
Survival Analysis of Lung Adenocarcinoma Patients with Exon 19 Del and 21 L858R Mutations Receiving EGFR-TKI Treatment
101-107
Abstract : 572
PDF : 535
The Effect of Anemia on Prognostic in Non-Small Cell Lung Cancer Patients Receiving Platinum-Based Chemotherapy
120-129
Abstract : 518
PDF : 303
Prognosis of Tyrosine Kinase Inhibitor Therapy for Non-Small Cell Lung Cancer
140-146
Abstract : 187
PDF : 113
Implementing Palliative and End-of-Life Care in Lung Cancer: When to Start?
64-71
Abstract : 781
PDF : 627
The Time to Progression in Lung Adenocarcinoma Patients Receiving First- and Second-Generation EGFR-TKI in Indonesia
22-30
Abstract : 581
PDF : 340
The Role of Thromboelastography in Heparin Therapy for COVID-19 Patients
119-125
Abstract : 666
PDF : 322
Giant Cell Lung Carcinoma: A Case Report of a Rare Histology Type of Non-Small Cell Lung Cancer
143-148
Abstract : 609
PDF : 376
Problem Terapeutik pada Empiema Terlokulasi karena Tuberkulosis [Theurapetic Problem in Tuberculosis Loculated Empyema]
86-93
Abstract : 1478
PDF : 5569
1 - 15 of 15 items